OTCPK:AMBF.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Ambu A/S provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally. More Details


Snowflake Analysis

Reasonable growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has Ambu's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AMBF.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-1.9%

AMBF.F

-3.3%

US Medical Equipment

-3.3%

US Market


1 Year Return

n/a

AMBF.F

13.7%

US Medical Equipment

10.9%

US Market

Return vs Industry: Insufficient data to determine how AMBF.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how AMBF.F performed against the US Market.


Shareholder returns

AMBF.FIndustryMarket
7 Day-1.9%-3.3%-3.3%
30 Day-26.6%-2.5%-5.7%
90 Day-23.9%12.2%8.2%
1 Yearn/a14.7%13.7%13.4%10.9%
3 Yearn/a69.0%64.7%34.9%25.9%
5 Yearn/a140.9%122.6%84.6%63.8%

Price Volatility Vs. Market

How volatile is Ambu's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Ambu undervalued compared to its fair value and its price relative to the market?

284.44x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: AMBF.F ($25.86) is trading above our estimate of fair value ($23.13)

Significantly Below Fair Value: AMBF.F is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: AMBF.F is poor value based on its PE Ratio (284.4x) compared to the US Medical Equipment industry average (49.6x).

PE vs Market: AMBF.F is poor value based on its PE Ratio (284.4x) compared to the US market (17.8x).


Price to Earnings Growth Ratio

PEG Ratio: AMBF.F is poor value based on its PEG Ratio (7.5x)


Price to Book Ratio

PB vs Industry: AMBF.F is overvalued based on its PB Ratio (17.4x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Ambu forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

37.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMBF.F's forecast earnings growth (37.7% per year) is above the savings rate (2.2%).

Earnings vs Market: AMBF.F's earnings (37.7% per year) are forecast to grow faster than the US market (23% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMBF.F's revenue (17.9% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: AMBF.F's revenue (17.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AMBF.F's Return on Equity is forecast to be low in 3 years time (18.6%).


Next Steps

Past Performance

How has Ambu performed over the past 5 years?

11.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMBF.F has a large one-off loss of DKK208.0M impacting its June 30 2020 financial results.

Growing Profit Margin: AMBF.F's current net profit margins (4.4%) are lower than last year (17.4%).


Past Earnings Growth Analysis

Earnings Trend: AMBF.F's earnings have grown by 11% per year over the past 5 years.

Accelerating Growth: AMBF.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AMBF.F had negative earnings growth (-71.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.8%).


Return on Equity

High ROE: AMBF.F's Return on Equity (6.1%) is considered low.


Next Steps

Financial Health

How is Ambu's financial position?


Financial Position Analysis

Short Term Liabilities: AMBF.F's short term assets (DKK1.2B) exceed its short term liabilities (DKK1.1B).

Long Term Liabilities: AMBF.F's short term assets (DKK1.2B) do not cover its long term liabilities (DKK1.4B).


Debt to Equity History and Analysis

Debt Level: AMBF.F's debt to equity ratio (49%) is considered high.

Reducing Debt: AMBF.F's debt to equity ratio has reduced from 93.8% to 49% over the past 5 years.

Debt Coverage: AMBF.F's debt is well covered by operating cash flow (31%).

Interest Coverage: AMBF.F's interest payments on its debt are well covered by EBIT (15.7x coverage).


Balance Sheet


Next Steps

Dividend

What is Ambu current dividend yield, its reliability and sustainability?

0.22%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: AMBF.F's dividend (0.22%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.71%).

High Dividend: AMBF.F's dividend (0.22%) is low compared to the top 25% of dividend payers in the US market (4.89%).


Stability and Growth of Payments

Stable Dividend: AMBF.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: AMBF.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: AMBF.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMBF.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.5yrs

Average management tenure


CEO

Juan-Jose Gonzalez (46 yo)

1.33yrs

Tenure

kr.7,800,000

Compensation

Mr. Juan-Jose Gonzalez has been Chief Executive Officer of Ambu A/S since May 15, 2019 and also had been its President since 2019 until 2019. He serves as Member of Executive Board at Ambu A/S. He is an en ...


CEO Compensation Analysis

Compensation vs Market: Juan-Jose's total compensation ($USD1.22M) is below average for companies of similar size in the US market ($USD7.43M).

Compensation vs Earnings: Insufficient data to compare Juan-Jose's compensation with company performance.


Leadership Team

NamePositionTenureCompensationOwnership
Juan-Jose Gonzalez
CEO & Member of Executive Board1.33yrskr.7.80m0.065%
DKK 4.3m
Michael Hojgaard
CFO, Executive VP of Global Finance7.67yrskr.3.90m0.015%
DKK 1.0m
Henrik Ankjær
Executive Vice President of Global Operations1.92yrsno datano data
Nicolai Thomsen
IR Managerno datano datano data
Anders Williamsson
Managing Directorno datano datano data
Måns Barsne
Executive Vice President of Global Innovation & Chief Innovation Officer5.67yrsno datano data
Steven Block
CEO & President of USA7.42yrsno datano data
Chresten Christensen
Director General of Ambu S.R.L. & Ambu S.L.no datano datano data
Keith McCallum
Managing Director of Ambu UK19.5yrsno datano data
Johannes Pick
Managing Director of Ambu GmbHno datano datano data

6.5yrs

Average Tenure

56.5yo

Average Age

Experienced Management: AMBF.F's management team is seasoned and experienced (6.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lars Rasmussen
Chairman of the Board0.75yrno datano data
Christian Sagild
Independent Director8.67yrskr.450.00k0.097%
DKK 6.4m
Mikael Worning
Independent Vice Chairmanno datakr.700.00k0.027%
DKK 1.8m
Henrik Wulff
Independent Director4.75yrskr.400.00k0.0043%
DKK 283.1k
Jakob Kristensen
Employee Representative Director7.67yrskr.300.00k0.0027%
DKK 177.5k
Britt Jensen
Director0.75yrno datano data
Oliver Johansen
Independent Director4.75yrskr.400.00k0.0092%
DKK 610.4k
Thomas Henriksen
Employee Representative Director3.67yrskr.300.00k0.0039%
DKK 255.4k
Jakob Koch
Employee Representative Director3.67yrskr.300.00k0.0010%
DKK 68.6k

4.2yrs

Average Tenure

49yo

Average Age

Experienced Board: AMBF.F's board of directors are considered experienced (4.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Ambu A/S's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ambu A/S
  • Ticker: AMBF.F
  • Exchange: OTCPK
  • Founded: 1937
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr.42.057b
  • Listing Market Cap: kr.6.599b
  • Shares outstanding: 247.90m
  • Website: https://www.ambu.com

Number of Employees


Location

  • Ambu A/S
  • Baltorpbakken 13
  • Ballerup
  • Capital Region of Denmark
  • 2750
  • Denmark

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMBU BCPSE (OMX Nordic Exchange Copenhagen)YesClass B SharesDKDKKAug 1992
AMBF.FOTCPK (Pink Sheets LLC)YesClass B SharesUSUSDAug 1992
AMBUBCBATS-CHIXE (BATS 'Chi-X Europe')YesClass B SharesGBDKKAug 1992
0MJFLSE (London Stock Exchange)YesClass B SharesGBDKKAug 1992
AMBU NBMV (Bolsa Mexicana de Valores)YesClass B SharesMXMXNAug 1992
AMBB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDJul 2017

Biography

Ambu A/S provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics in Europe, North America, and internationally. The company offers anesthesia produc ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/24 05:52
End of Day Share Price2020/09/22 00:00
Earnings2020/06/30
Annual Earnings2019/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.